vVARDIS (VVVV) is a Healthcare company in the Medical Instruments Supplies industry. It has a market capitalization of $2.72B and a free-cash-flow yield of -0.7%. Over the most recent reported fiscal year, revenue grew 148.5%. Nama's AI scorecard rates it Sell, 2.5 out of 10.
AI scorecard
Sell · 2.5/10
Clearly negative, short of the bottom band. As of Nov 20, 2026.
Shariah screen
Can't Tell
A figure the screen needs is missing, so it can't tell.
Off its high
-14.2%
How far the last close sits under the highest price of the past five years.
Nama's AI scorecard currently rates vVARDIS Sell (2.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
Is VVVV Shariah compliant?
Nama's AAOIFI-style screen reads vVARDIS as Can't Tell. A figure the screen needs is missing, so it can't tell.